Cancer Genetic Epidemiology

AAA

TECHNOLOGY

Established to study the genetic causes and origins of common cancers (e.g. breast, melanoma, colon, and prostate) and to develop DNA based diagnostics. Focus is on developing approaches to gene mapping and gene isolation for future applications in cancer diagnosis and therapy.

CENTER NEWS
 
HIGHLIGHTS
 
  • The Center has cloned the 17q linked breast cancer gene and the 9p linked melanoma gene.
  • Myriad Genetics employes 770 people with revenues of approximately $100MM
SPIN OUT COMPANIES
BENEFITING COMPANIES

 

CENTER'S WEBSITE
 
CONTACT INFORMATION
 Mark Skolnick
(801) 584-3643
mark@myriad.com